Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04126551 · ClinicalTrials.gov registry record
Mitochondrial Methylation in Type 2 Diabetes
A clinical trial of Obesity and Diabetes Mellitus, Type 2, sponsored by University of Arizona.
- Completed
- Registry status
- 27
- Enrollment target
- 1
- Study location
NCT04126551 is a study of Obesity and Diabetes Mellitus, Type 2 that has completed, run by University of Arizona. The registered enrollment target is 27 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04126551, a study of Obesity and Diabetes Mellitus, Type 2, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of this proposal is to determine whether DNA methylation of the mitochondrial DNA impairs mitochondrial function in insulin resistant states such as overweight/obesity and type 2 diabetes.
Conditions Studied
Interventions
- OTHER Methylation status
Study Locations (1)
Arizona
- Clinical and Translational Research Center (CaTS) - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2019-07-23 |
| Est. Completion | 2023-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04126551
The ClinicalTrials.gov registry entry for NCT04126551 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Methylation status is the first listed.
NCT04126551 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT04126551 about?
NCT04126551 is a clinical study titled "Mitochondrial Methylation in Type 2 Diabetes". The overarching goal of this proposal is to determine whether DNA methylation of the mitochondrial DNA impairs mitochondrial function in insulin resistant states such as overweight/obesity and type 2 diabetes.
What is the current status of trial NCT04126551?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2019-07-23. Estimated completion is 2023-12-31.
What conditions does trial NCT04126551 study?
This clinical trial studies the following conditions: Obesity, Diabetes Mellitus, Type 2, Overweight, Insulin Resistance.
What interventions are being tested in trial NCT04126551?
The interventions under investigation include: Methylation status (OTHER).
Who is sponsoring clinical trial NCT04126551?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04126551 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.